• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


JC Scott

Latest:

Biosimilar Adoption, Legislative Action With PBMs: JC Scott

JC Scott, CEO and president of The Pharmaceutical Care Management Association, discusses current efforts in increasing biosimilar adoption and pharmacy benefit manager (PBM) reform.


Nauman Chaudary, MD, FACP, FCCP

Latest:

Final Thoughts on Bronchiectasis Management

Panelists discuss how bronchiectasis is more common than previously thought, with growing awareness, research, and specialized centers improving diagnosis and treatment options, though challenges remain in standardizing care and securing insurance coverage for therapies.


Steven P. Dehmer, PhD

Latest:

A Learning Health Care Community: Integrating Research and Practice at Scale

This article presents a case study of how stakeholders in one state came together to integrate practice and research that is a step beyond a learning health care system.


Hilary K. Michel, MD

Latest:

The Biosimilar Shift: Trending Infliximab Biosimilar Utilization and Associated Cost Savings for Commercial Insurance

Infliximab biosimilars created price competition causing insurance claims costs for infliximab originator and infliximab biosimilars to decrease, generating significant savings to the health care system.


Dirk Arnold, MD, PhD

Latest:

Exploring Amivantamab's Potential in Colorectal Cancer: Dirk Arnold, MD, PhD

Dirk Arnold, MD, PhD, medical director, Asklepios Tumour Biology Centre, discusses the trial design of a study comparing amivantamab with standard chemotherapy to potentially improve treatment outcomes.


Ashwin Avhad

Latest:

Contributor: Top 3 Future Therapies to Drive Hemophilia Treatment Market Growth

The trends in the hemophilia treatment market are gaining momentum with increasing incidences of hemophilia A and B and staggering need for their treatments, including gene, anti-tissue factor pathway inhibitor, and factor replacement therapies.


Rachael M. Moloney, MHS

Latest:

Proposed Framework for Patient-Centered Outcomes-Based Measures in Alternative Payment Models

Synthesis of multistakeholder perspectives from a mixed-methods study identifies guiding characteristics for outcomes-based quality measures in future, more patient-centered alternative payment models.


Cate Lockhart, PharmD, PhD

Latest:

Real-World Evidence Standards Bridge Research, Clinical Decision-Making: Cate Lockhart, PharmD, PhD

Real-world evidence helps pharmaceutical companies and payers communicate more effectively.


Jonathan Rothwell, PhD

Latest:

Contributor: How Health Care Companies Can Use Upskilling to Navigate the Great Resignation

The Great Resignation is sending health care workers out of the industry in massive numbers, and this, coupled with the ongoing transformation of health care, is creating the perfect storm. Alleviating their stress, burnout, and disengagement is a necessary first step. But the proper development, training, and upskilling is also crucial.


Adam Brufsky, MD, PhD

Latest:

Invest in Human Capital to Improve Breast Cancer Care Delays: Adam Brufsky, MD, PhD

Delays in breast cancer diagnosis and treatment highlight the need for improved human capital investment in health care systems, explains Adam Brufsky, MD, PhD.


Zhongying Li, MS

Latest:

Knowledge, Attitude, and Practices Regarding ChatGPT Among Health Care Professionals

This web-based cross-sectional study indicated that health care professionals in China had poor knowledge, positive attitudes, and proactive practices in regard to ChatGPT.


Devraj Sukul, MD, MSc

Latest:

Out-of-Pocket Spending for Cardiac Rehabilitation and Adherence Among US Adults

Among commercial and Medicare supplemental beneficiaries with cost sharing, higher out-of-pocket spending for the first cardiac rehabilitation session was associated with lower program adherence.


Liberty Greene, MS, MEd

Latest:

Distinct Health Care Use Patterns of Patients With Chronic Gastrointestinal Diseases

Patients with complex chronic disease can be grouped by varying propensity for health care continuity patterns, which could be harnessed to personalize health care utilization interventions.


Jennifer Hsiao, MD

Latest:

Key Takeaways on HS Care: Multidisciplinary Collaboration and Equity Solutions

Panelist discusses how health systems can improve communication and coordination among specialists through integrated care models and digital platforms. Centers of Excellence promote health equity by providing specialized care in underserved areas, reducing disparities. A unified approach ensures efficient, patient-centered care, enhancing outcomes for all.


Saikrishna Patibandla, MD, MS

Latest:

AHA Telemetry Guidelines Improve Telemetry Utilization in the Inpatient Setting

Using Plan-Do-Study-Act cycles, the studied intervention reduced hospital inpatient telemetry time by 51.25% while increasing American Heart Association (AHA) guideline–based usage.


Inga Gruß, PhD

Latest:

Challenges With Implementing the Diabetes Prevention Program for Medicare Beneficiaries in an Integrated Health System

This study presents challenges of implementing the CDC-approved Diabetes Prevention Program for Medicare beneficiaries at a large, integrated health care delivery system.


Pu-Kai Tseng

Latest:

Temporal Shift in Prevalence of Heart Failure Diagnoses and Comorbidities Within 2 US Integrated Health Systems

The analysis highlighted a shift in heart failure diagnoses, with hypertensive heart disease with and without chronic kidney disease as prevalent diagnoses, underlining coding variability and implications for research.


Robert H. Aseltine Jr, PhD

Latest:

Accountable Care Organizations and HPV Vaccine Uptake: A Multilevel Analysis

The authors evaluated whether adolescents receiving care at accountable care organizations (ACOs) vs non-ACOs were more likely to initiate and complete the human papillomavirus (HPV) vaccination series.


Antonio Urbina, MD

Latest:

Innovation in Long-Acting Prevention Is the Future of HIV: Antonio Urbina, MD

Although a cure is likely still a ways off, continuing to pursue long-acting injectable treatments and PrEP is key to reducing cases of HIV.


Chi-Hua Lu, PharmD

Latest:

Pharmacists and Transitions of Care From Emergency Department to Home

Pharmacists’ roles in transitions of care continue to evolve. Evaluation of pharmacist-led interventions as patients transition from emergency department to home is needed.




Yuqing Gao, MS

Latest:

Endoscopist-Directed Sedation Rarely Fails: Implications for the Value of Anesthesia Assistance for Routine GI Endoscopy

Failed sedation for routine gastrointestinal (GI) endoscopy is extremely rare, warranting a return to endoscopist-directed sedation, rather than costly anesthesia-assisted sedation, as the default sedation standard.


Ademola Osinubi, MS

Latest:

The Hepatitis B Care Cascade Using Administrative Claims Data, 2016

Analysis of a large, nationally representative claims database to longitudinally monitor enrollees with hepatitis B showed that 36% received recommended care and 18% were prescribed treatment.


Derek A. Kaknes, BS

Latest:

Interventional Analytics in Skilled Nursing Facilities Associated With Reduced Readmissions

A retrospective analysis of 30-day risk-adjusted readmission rates among skilled nursing facilities (SNFs) between 2017 and 2022 compared those that had implemented an interventional analytics platform and other SNFs.


Kristin K. Soreide, PharmD, BCPS

Latest:

Pharmacist Hypertension Management Using an Electronic Health Record–Based Approach

The authors studied the impact of a pharmacist intervention on blood pressure control compared with usual care.



Calum Yacoubian, MD

Latest:

Contributor: How Payers Are Applying AI to Solve the Problem of Incomplete Data—3 Use Cases

In this column, Calum Yacoubian, MD, outlines how artificial intelligence, specifically, natural language processing, can help address gaps in patient data.


Jenee Williams, MBA

Latest:

Breaking Barriers: Partnerships to Improve Diabetic Eye Health in Alabama

This article reviews barriers to diabetic eye health across Alabama and highlights a partnership with Genentech and the American Diabetes Association to address this issue.


David G. Stevenson, PhD

Latest:

Risk Adjusting for Medicaid Participation in Medicare Advantage

When comparing risk-adjustment approaches based on Medicaid status of Medicare beneficiaries, this analysis found that predicted spending levels varied depending on states’ Medicaid eligibility criteria.

© 2026 MJH Life Sciences
AJMC®
All rights reserved.